6TH INTERNATIONAL CONFERENCE ON MYELODYSPLASTIC SYNDROMES

April 26-28, 2018 – Mandelieu, France 

Chairs: P. Fenaux (Paris), U. Platzbecker (Dresden), M. Sekeres (Cleveland)

The conference will be held in the Mandelieu Congress Centre in Mandelieu, France. 

The meeting will bring together approximately 400 specialists in the field, ranging from key opinion leaders to senior and junior haematologists from all over the world. Multiple opportunities for high- level scientific exchange and informal international networking will be provided.

More information here

 

DEADLINE FOR ABSTRACTS: MARCH 1st, 2018

The programme will include:
- Plenary Sessions
- Debates
- Panel Discussions
- Simultaneous Meet the Expert Sessions
- Poster Sessions

Topics:
1. Etiology of MDS
2. Biology of MDS: genetic abnormalities
3. Biology of MDS: stem cells and the microenvironment
4. Diagnostic workup and prognostic factors in MDS
5. Specific subtypes of MDS, based on morphology and molecular biology
6. Treatment of MDS

Full Programme
Full Faculty


IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator

calculator

Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

MDS Fact Sheet

Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BSH Guidelines

This is an external link to the home of the British Society for Haematology (BSH). 

BSH Logo Strapline RGB

Click here